Loading candles…
Sequent Scientific Limited, previously known as Sequent Scientific Ltd. before its merger and renaming as Viyash Scientific Ltd., is an integrated pharmaceutical company in the animal health, pharmaceutical, and life sciences industries. The company offers a broad portfolio of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), and analytical services. It emphasizes research and development, manufacturing, and compliance with global regulatory standards. Operating across more than five continents and serving over 100 countries, including markets in Europe, the USA, and emerging economies, Sequent Scientific is recognized as a leading animal health company in India. The company's evolution through the merger has positioned it as a comprehensive pharmaceutical player, although precise details regarding incorporation, headquarters, founders, management, subsidiaries, or stock listings are not specified.
This page is a live market overview for VIYASH SCIENTIFIC LIMITED (VIYASH) on the NSE. As a listed security, VIYASH SCIENTIFIC LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VIYASH before placing trades on tick2trade.
As of the latest feed, VIYASH last traded at ₹277 on NSE, up ₹4.35 (1.60%) from the previous close of ₹272.65. Today's session range is ₹271.3 – ₹281, against a 52-week band of ₹167.1 – ₹298. Traded volume today stands at 20.67L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VIYASH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VIYASH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VIYASH SCIENTIFIC LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VIYASH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VIYASH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 11 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 19 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 20 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.